Table 1: Clinical characteristics of the study population.

 

Total

(N = 110)

50 years

(N = 25)

> 50 years

(N = 85)

P value

Age (years)

59 ± 12

41 ± 6.49

64 ± 8

 

Gender

Male (N,%)

78 (71%)

19 (76%)

59 (69%)

0.356

Female (N,%)

32 (29%)

6 (24%)

26 (31%)

Risk factors

Hypertension

70 (64%)

10 (40%)

60 (71%)

0.006

Diabetes

34 (31%)

7 (28%)

27 (32%)

0.462

Smoking

31 (28%)

14 (56%)

17 (20%)

0.001

Renal disease

15 (14%)

3 (12%)

12 (14%)

0.542

Alcohol

7 (6%)

5 (20%)

2 (2%)

0.006

Drug abuse

5 (5%)

4 (16%)

1(1%)

0.002

APT

17 (15%)

1 (4%)

16 (19%)

0.059

ACT

7 (6%)

0 (0%)

7 (8%)

0.155

GCS

Grade I

39 (35%)

10 (40%)

29 (34%)

0.754

Grade II

29 (26%)

6 (24%)

23 (27%)

 

Grade III

22 (20%)

6 (24%)

16 (18.8%)

 

Grade IV

20 (18%)

3 (12%)

17 (20%)

 

APC: Antiplatelet Therapy; ACP: Anticoagulants Therapy